icone plus
Contact Abonnez-vous aux actualités
Reason for request
- Re-assessment of Actual Benefit on the transparency Committee’s own initiative in accordance with article R 163-21 of the Social Security Code and changes to Summary of Product Characteristics.
Clinical Benefit
Moderate
The actual benefit of AETOXISCLEROL is moderate.
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
jwDjPVu3vMn4x1Q6
Listen
